Lieutenant General (Ret.) Rick Lynch
With over 34 years in the US Army at his heel, Lieutenant General (Ret.) Rick Lynch has distinguished himself as an exceptional leader and strategist through his chameleon-like ability to adapt to change despite the most challenging obstacles. From surmounting his parents’ inability to pay for college by gaining entry to West Point to leading “The Surge” in Iraq as Army General with only six weeks to prepare, Lieutenant General Lynch has constructed a disciplined and effective mantra for success, which he shares with audiences across the country today.
From company (about 100 soldiers) to corps (about 65,000 soldiers) to the head of all US Army installations, Lynch steadily climbed his way up, eventually commanding at all levels. Matching the professional acumen of established business leaders, he was responsible for managing all the installations in the US Army with an annual budget of $12 billion and a workforce of 120,000. Combining this impeccable work ethic with an open heart, he also effectively lowered divorce and suicide rates at Fort Hood, Texas, by outlawing weekend work and mandating soldier family time.
Lynch’s book, Adapt or Die: Battle Tested Principles for Leaders, provides unprecedented clarity to leaders from all walks of life. In it, he offers insight born from overcoming adversity on both the battlefield and in the boardroom. With refreshing directness, he shares how to gain the confidence needed to lead in our ever-changing world. His new book, Work Hard Pray Hard: The Power of Faith in Action will be released in April 2017.
In his commanding presentations, Lynch captivates audiences with the tenor of his voice and the approachable, conversational nature of his tone. Drawing on his personal experience in and out of combat, he powerfully illustrates his principles, from the foundation of business leadership to the need for resiliency and engagement.
Connect with Rick on Linkedin
Martin Layding has 20 years progressive Financial experience across multiple industries and corporate financial disciplines. Marty’s focus has been on building strong relationship with multifunctional partners to drive shareholder value through topline and margin enhancing initiatives.
Currently CFO of Coach, Inc.’s International Business Group; his previous experiences include financial leadership roles in Supply Chain, FP&A and Strategy teams for Procter & Gamble, Novartis Consumer Health, Coach, Inc. and Wolters Kluwer Health.
Connect with Marty on Linkedin
Al Reicheg has spent 25+ years in the healthcare industry. The first 15+ years were spent on the commercial side of life sciences. He held positions of increasing responsibility including sales, sales training, sales management, marketing, managed markets, and business development for a number of pharma companies.
After catching the entrepreneurial bug, Al spent the past 10 years building and executing a commercialization strategy for an entrepreneurial data analytics and predictive modeling company. Through the years, he has had the opportunity to evaluate the strengths and weaknesses of hundreds of healthcare service companies – from both the corporate and service provider perspectives. After leading the process of identifying a buyer and negotiating a sale of his previous company, to a healthcare private equity firm, Al launched Sea Change Healthcare Consulting. Al’s deep commercial insights, market savvy, and unwavering commitment to integrity have helped him build a broad C Suite network. A strong believer in karma; if he can’t help you solve a problem, Al probably knows someone who can and is happy to make the connection.
About Sea Change Healthcare Consulting
Sea Change is Al’s latest venture and is exclusively focused on providing strategic advisory services to health care service companies. Areas of expertise include commercialization, sales & marketing strategic/tactical planning, business development, corporate development, managing accelerated growth, and M&A strategy. Sea Change works closely with clients to identify objectives, accelerate transformation, and help companies achieve their goals…faster!
Connect with Al on Linkedin
Lou Sanquini has more than 20 years of experience in the pharmaceuticals industry. Following sixteen years with GSK in sales, managed care and marketing, he moved to Meda where responsibilities included leadership roles in consumer, physician and portfolio marketing. Overall, he launched eleven brands, including a number of novel brands, “me too,” and loss of exclusivity follow-on brands.
He joined QualityHealth, a pharmaceutical marketing services company, to assist in the pivot from plateau to growth. Subsequent to the introduction two new verticals and a number of products, conceived to effectively meet the industry’s unmet needs, the company grew sales by 30%. His efforts significantly contributed to the sale of QualityHealth to Sharecare.
Currently, Lou is EVP of Marketing & BD at Sharecare and holds a Board Position with the New York City Health Business Leaders in addition to the Advisory Board Position with Zensights. Additionally, he is a member of the St. Peter’s Church Council where he heads-up community and fund raising efforts for the 225 year old institution.
Lou graduated with a B.S. from West Chester University of Pennsylvania. He lives in NYC with his wife and two daughters.
Connect with Lou on Linkedin
Brian J. Smith
Brian J. Smith graduated from Loras College in 1977 – B.A. in Business Administration. He went on to obtain an M.B.A. from Dominican University in 1984 and is an Alumnus of The Harvard Business School, having completed the OPM Program in 2006.
Brian began his career in the health care industry as a sales representative for Johnson and Johnson’s Ethicon Division. He joined Boehringer Ingleheim as a hospital sales representative in Chicago where he later relocated to the company’s home office in Ridgefield, Connecticut to take on various cardiovascular marketing positions.
In 1986, Brian joined Lederle Labs’ International Division where he headed up the company’s marketing initiative to launch new cardiovascular products in Europe and the Far East. He went on to hold senior marketing and sales positions at Forest Laboratories, Watson Pharmaceuticals and Boron LePore & Associates. He was a Division President -Corporate Officer of Boron LePore during the IPO in 1998.
Brian has served as CEO and Co-founder of Argent Development Group since 2004. Brian was Co-founder of Manchester Pharmaceuticals which was sold to Retrophin in 2014. Presently, he serves as Co-founder and COO of Melbourne Laboratories, and Co- founder and President of Valcrest Pharmaceuticals.
In addition to Argent, Brian is on the Board of Directors of several privately held pharmaceutical, drug development and health care companies. In 2015, he joined the Board of Directors of DermAvance Pharmaceuticals.
Brian is a member of the Board of Regents for Loras College and is a member of The Executive Committee. Brian is on the Board of Trustees for Cristo Rey High School in Brooklyn New York.
Connect with Brian on Linkedin